Ghent University Academic Bibliography

Advanced

In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies

Ludovicus Staelens, Ruth Oltenfreiter UGent, Filip Dumont, RN WATERHOUSE, K VANDENBULCKE, PETER BLANCKAERT UGent, Rudi Dierckx UGent and Guido Slegers UGent (2005) NUCLEAR MEDICINE AND BIOLOGY. 32(2). p.193-200
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
NUCLEAR MEDICINE AND BIOLOGY
Nucl. Med. Biol.
volume
32
issue
2
pages
193-200 pages
publisher
ELSEVIER SCIENCE INC
Web of Science type
Article
Web of Science id
000227689100011
JCR category
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
JCR impact factor
2.129 (2005)
JCR rank
29/84 (2005)
JCR quartile
2 (2005)
ISSN
0969-8051
language
English
UGent publication?
yes
classification
A1
id
307744
handle
http://hdl.handle.net/1854/LU-307744
date created
2005-05-23 15:55:00
date last changed
2016-12-19 15:42:19
@article{307744,
  author       = {Staelens, Ludovicus and Oltenfreiter, Ruth and Dumont, Filip and WATERHOUSE, RN and VANDENBULCKE, K and BLANCKAERT, PETER and Dierckx, Rudi and Slegers, Guido},
  issn         = {0969-8051},
  journal      = {NUCLEAR MEDICINE AND BIOLOGY},
  language     = {eng},
  number       = {2},
  pages        = {193--200},
  publisher    = {ELSEVIER SCIENCE INC},
  title        = {In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies},
  volume       = {32},
  year         = {2005},
}

Chicago
Staelens, Ludovicus, Ruth Oltenfreiter, Filip Dumont, RN WATERHOUSE, K VANDENBULCKE, Peter Blanckaert, Rudi Dierckx, and Guido Slegers. 2005. “In Vivo Evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a Potential Sigma Receptor Ligand for SPECT Studies.” Nuclear Medicine and Biology 32 (2): 193–200.
APA
Staelens, Ludovicus, Oltenfreiter, R., Dumont, F., WATERHOUSE, R., VANDENBULCKE, K., Blanckaert, P., Dierckx, R., et al. (2005). In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies. NUCLEAR MEDICINE AND BIOLOGY, 32(2), 193–200.
Vancouver
1.
Staelens L, Oltenfreiter R, Dumont F, WATERHOUSE R, VANDENBULCKE K, Blanckaert P, et al. In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies. NUCLEAR MEDICINE AND BIOLOGY. ELSEVIER SCIENCE INC; 2005;32(2):193–200.
MLA
Staelens, Ludovicus, Ruth Oltenfreiter, Filip Dumont, et al. “In Vivo Evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a Potential Sigma Receptor Ligand for SPECT Studies.” NUCLEAR MEDICINE AND BIOLOGY 32.2 (2005): 193–200. Print.